Park JY, Georges D, Alberts CJ, Bray F, Clifford G, Baussano I. Global lifetime estimates of expected and preventable gastric cancers across 185 countries. Nat Med. 2025;31:3020–7.
Panahizadeh R, Panahi P, Asghariazar V, Makaremi S, Noorkhajavi G, Safarzadeh E. A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies. Cancer Cell Int. 2025;25:23.
Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HWM, Janjigian YY, et al. Gastric cancer. Lancet. 2025;405:2087–102.
Luo D, Zhou J, Ruan S, Zhang B, Zhu H, Que Y, et al. Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies. Cell Death Dis. 2025;16:75.
Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31–46.
Broadfield LA, Pane AA, Talebi A, Swinnen JV, Fendt SM. Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell. 2021;56:1363–93.
Won Y, Jang B, Lee SH, Reyzer ML, Presentation KS, Kim H, et al. Oncogenic Fatty Acid Metabolism Rewires Energy Supply Chain in Gastric Carcinogenesis. Gastroenterology. 2024;166:772–86.e714
Terry AR, Nogueira V, Rho H, Ramakrishnan G, Li J, Kang S, et al. CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression. Cell Metab. 2023;35:2060–76.e2069
Mallick R, Bhowmik P, Duttaroy AK. Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment. Biomed Pharmacother. 2023;167:115591.
Kamphorst JJ, Cross JR, Fan J, de Stanchina E, Mathew R, White EP, et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci USA. 2013;110:8882–7.
Su X, Abumrad NA. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol Metab. 2009;20:72–77.
Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal. 2009;2:re3.
Samovski D, Jacome-Sosa M, Abumrad NA. Fatty Acid Transport and Signaling: Mechanisms and Physiological Implications. Annu Rev Physiol. 2023;85:317–37.
Yang Y, Liu X, Yang D, Li L, Li S, Lu S, et al. Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression. Metabolism. 2024;155:155905.
Jiang M, Karsenberg R, Bianchi F, van den Bogaart G. CD36 as a double-edged sword in cancer. Immunol Lett. 2024;265:7–15.
Xia L, Zhou Z, Chen X, Luo W, Ding L, Xie H, et al. Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance. Biomed Pharmacother. 2023;168:115834.
Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541:41–5.
Jiang M, Wu N, Xu B, Chu Y, Li X, Su S, et al. Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis. Theranostics. 2019;9:5359–73.
Pan J, Fan Z, Wang Z, Dai Q, Xiang Z, Yuan F, et al. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3beta/beta-catenin pathway. J Exp Clin Cancer Res. 2019;38:52.
Aoki T, Kinoshita J, Munesue S, Hamabe-Horiike T, Yamaguchi T, Nakamura Y, et al. Hypoxia-induced CD36 expression in gastric cancer cells promotes peritoneal metastasis via fatty acid uptake. Ann Surg Oncol. 2023;30:3125–36.
Glatz JFC, Nabben M, Luiken J. CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis. Curr Opin Lipido. 2022;33:103–11.
Wang J, Guo H, Zheng LF, Li P, Zhao TJ. Context-specific fatty acid uptake is a finely-tuned multi-level effort. Trends Endocrinol Metab. 2025;36:577–90.
Singh I, Onogi Y, Menezes F, Khasanova D, Kang L, Wang C, et al. NRAC controls CD36-mediated fatty acid uptake in adipocytes and lipid clearance in vivo. EMBO J. 2025;44:5037–65.
Ibanez S, Giolito MV, Al-Siyabi S, Serafimov K, Laloux F, Dierge E, et al. Acidosis forces fatty acid uptake and metabolism in cancer cells regardless of genotype. Adv Sci (Weinh). 2025;12:e05436.
Zhang Q, Li J, Liu X, Chen X, Zhu L, Zhang Z, et al. Inhibiting CD36 palmitoylation improves cardiac function post-infarction by regulating lipid metabolic homeostasis and autophagy. Nat Commun. 2025;16:6602.
Li M, Jia H, Zhang L, Chen P, Wang S, Mao Y, et al. Palmitoylation-dependent modulation of CD36 trafficking and signaling integrates lipid uptake with metabolic disease pathogenesis. Pharm Res. 2025;220:107935.
Song P, Jiang Q, Wu X, Bu L, Xie W, Wei W, et al. Palmitic acid and palmitoylation in cancer: understanding, insights, and challenges. Innov (Camb). 2025;6:100918.
Li E, Zang R, Kawagishi T, Zhang W, Iyer K, Hou G, et al. Fatty acid 2-hydroxylase facilitates rotavirus uncoating and endosomal escape. Proc Natl Acad Sci USA. 2025;122:e2511911122.
Li H, Lin L, Huang X, Lu Y, Su X. 2-Hydroxylation is a chemical switch linking fatty acids to glucose-stimulated insulin secretion. J Biol Chem. 2024;300:107912.
Li Y, Wang C, Huang Y, Fu R, Zheng H, Zhu Y, et al. C. Elegans fatty acid two-hydroxylase regulates intestinal homeostasis by affecting heptadecenoic acid production. Cell Physiol Biochem. 2018;49:947–60.
Guo L, Zhang X, Zhou D, Okunade AL, Su X. Stereospecificity of fatty acid 2-hydroxylase and differential functions of 2-hydroxy fatty acid enantiomers. J Lipid Res. 2012;53:1327–35.
Guo L, Zhou D, Pryse KM, Okunade AL, Su X. Fatty acid 2-hydroxylase mediates diffusional mobility of Raft-associated lipids, GLUT4 level, and lipogenesis in 3T3-L1 adipocytes. J Biol Chem. 2010;285:25438–47.
Sun L, Yang X, Huang X, Yao Y, Wei X, Yang S, et al. 2-Hydroxylation of Fatty Acids Represses Colorectal Tumorigenesis and Metastasis via the YAP Transcriptional Axis. Cancer Res. 2021;81:289–302.
Yao Y, Yang X, Sun L, Sun S, Huang X, Zhou D, et al. Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer. EBioMedicine. 2019;41:256–67.
Ding L, Chen Z, Lu Y, Su X. Global Analysis of 2-Hydroxy Fatty Acids by Gas Chromatography-Tandem Mass Spectrometry Reveals Species-Specific Enrichment in Echinoderms. J Agric Food Chem. 2023;71:16362–70.
Eckhardt M. Fatty Acid 2-Hydroxylase and 2-Hydroxylated Sphingolipids: Metabolism and Function in Health and Diseases. Int J Mol Sci. 2023;24:4908.
Zhao L, Zhang C, Luo X, Wang P, Zhou W, Zhong S, et al. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol. 2018;69:705–17.
Zhang Y, Dong D, Xu X, He H, Zhu Y, Lei T, et al. Oxidized high-density lipoprotein promotes CD36 palmitoylation and increases lipid uptake in macrophages. J Biol Chem. 2022;298:102000.
Wang J, Hao JW, Wang X, Guo H, Sun HH, Lai XY, et al. DHHC4 and DHHC5 Facilitate Fatty Acid Uptake by Palmitoylating and Targeting CD36 to the Plasma Membrane. Cell Rep. 2019;26:209–21.e205.
Ruan C, Meng Y, Song H. CD36: an emerging therapeutic target for cancer and its molecular mechanisms. J Cancer Res Clin Oncol. 2022;148:1551–8.
Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122:4–22.
Li Q, Chen L, Yang L, Zhang P. FA2H controls cool temperature sensing through modifying membrane sphingolipids in Drosophila. Curr Biol. 2024;34:997–1009.e1006.
Zhou X, Huang F, Ma G, Wei W, Wu N, Liu Z. Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis. Signal Transduct Target Ther. 2022;7:370.
Terry AR, Hay N. Emerging targets in lipid metabolism for cancer therapy. Trends Pharm Sci. 2024;45:537–51.
Chen Y, Zhang J, Cui W, Silverstein RL. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate. J Exp Med. 2022;219:e20211314.
Glatz JFC, Heather LC, Luiken J. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease. Physiol Rev. 2024;104:727–64.
Guerrero-Rodriguez SL, Mata-Cruz C, Perez-Tapia SM, Velasco-Velazquez MA. Role of CD36 in cancer progression, stemness, and targeting. Front Cell Dev Biol. 2022;10:1079076.
Luo X, Zheng E, Wei L, Zeng H, Qin H, Zhang X, et al. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis. Cell Death Dis. 2021;12:328.
Fang Y, Shen ZY, Zhan YZ, Feng XC, Chen KL, Li YS, et al. CD36 inhibits beta-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nat Commun. 2019;10:3981.
Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37:2285–301.
Feng WW, Wilkins O, Bang S, Ung M, Li J, An J, et al. CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies. Cell Rep. 2019;29:3405–20.e3405
Khan AUH, Salehi H, Alexia C, Valdivielso JM, Bozic M, Lopez-Mejia IC, et al. Glucose starvation or pyruvate dehydrogenase activation induce a broad, ERK5-mediated, metabolic remodeling leading to fatty acid oxidation. Cells. 2022;11:1392.
Yang M, He J, Xia S, Wang Y, Xiong J, Liao C, et al. Investigation of the mixed origins of the MGC-803 cell line reveals that it is a hybrid cell line derived from HeLa. Hum Cell. 2024;37:560–6.
Zeng S, Wu F, Chen M, Li Y, You M, Zhang Y, et al. Inhibition of Fatty Acid Translocase (FAT/CD36) palmitoylation enhances hepatic fatty acid beta-oxidation by increasing its localization to mitochondria and interaction with long-chain Acyl-CoA Synthetase 1. Antioxid Redox Signal. 2022;36:1081–100.
Zeng H, Qin H, Liao M, Zheng E, Luo X, Xiao A, et al. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. Mol Metab. 2022;57:101428.